Anne Offermann

1.8k total citations
55 papers, 820 citations indexed

About

Anne Offermann is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Anne Offermann has authored 55 papers receiving a total of 820 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 22 papers in Oncology and 20 papers in Molecular Biology. Recurrent topics in Anne Offermann's work include Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Anne Offermann is often cited by papers focused on Prostate Cancer Treatment and Research (27 papers), Prostate Cancer Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (11 papers). Anne Offermann collaborates with scholars based in Germany, United States and Switzerland. Anne Offermann's co-authors include Sven Perner, Jutta Kirfel, Julika Ribbat‐Idel, Axel S. Merseburger, Verena Sailer, Wenzel Vogel, Stefan Duensing, Marie C. Hupe, Christian Idel and Rainer Kuefer and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Anne Offermann

48 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Offermann Germany 17 366 322 308 166 149 55 820
Zhiyong Ma China 16 261 0.7× 525 1.6× 642 2.1× 137 0.8× 136 0.9× 43 952
Qianya Qi United States 17 530 1.4× 283 0.9× 563 1.8× 434 2.6× 227 1.5× 25 1.1k
Loay Kassem Egypt 17 298 0.8× 216 0.7× 282 0.9× 132 0.8× 116 0.8× 51 802
Sarah Beck Germany 16 534 1.5× 199 0.6× 203 0.7× 89 0.5× 106 0.7× 30 1.0k
Frank Breitenbuecher Germany 18 728 2.0× 148 0.5× 278 0.9× 160 1.0× 114 0.8× 33 1.5k
Shi Chang United States 7 484 1.3× 404 1.3× 261 0.8× 205 1.2× 54 0.4× 9 904
Irene Rodríguez‐Hernández Spain 15 481 1.3× 76 0.2× 279 0.9× 161 1.0× 93 0.6× 21 877
Nikolaos Xenidis Greece 16 297 0.8× 233 0.7× 554 1.8× 372 2.2× 30 0.2× 46 936
John T. Isaacs United States 11 550 1.5× 443 1.4× 213 0.7× 172 1.0× 79 0.5× 12 992

Countries citing papers authored by Anne Offermann

Since Specialization
Citations

This map shows the geographic impact of Anne Offermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Offermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Offermann more than expected).

Fields of papers citing papers by Anne Offermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Offermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Offermann. The network helps show where Anne Offermann may publish in the future.

Co-authorship network of co-authors of Anne Offermann

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Offermann. A scholar is included among the top collaborators of Anne Offermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Offermann. Anne Offermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Das, Sunetra, et al.. (2025). Osteosarcoma Exosome Priming of Primary Human Lung Fibroblasts Induces an Immune Modulatory and Protumorigenic Phenotype. Cancer Research Communications. 5(4). 594–608. 2 indexed citations
2.
Ronaldson-Bouchard, Kacey, Anne Offermann, Dan Hasson, et al.. (2025). ATAD2 Drives Prostate Cancer Progression to Metastasis. Molecular Cancer Research. 23(5). 379–390. 1 indexed citations
3.
Zingue, Stéphane, Anne Offermann, Céline Henoumont, et al.. (2024). Kerstinginone, a new flavanone derivative from Commiphora kerstingii Engl. (Burseraceae) with potent apoptosis-inducing activity and inhibition of AKT/mTOR signaling pathway in non-sensitive prostate cancer cells. Journal of Ethnopharmacology. 338(Pt 2). 119073–119073. 1 indexed citations
4.
Offermann, Anne, Danny Jonigk, Mark Kühnel, et al.. (2024). CEACAM6 Promotes Lung MetastasisviaEnhancing Proliferation, Migration and Suppressing Apoptosis of Prostate Cancer Cells. Cancer Genomics & Proteomics. 21(4). 405–413.
5.
Offermann, Anne, Danny Jonigk, Mark Kuehnel, et al.. (2024). Comprehensive transcriptomic analysis of prostate cancer lung metastases. PLoS ONE. 19(8). e0306525–e0306525.
6.
Perner, Sven, et al.. (2023). Elevated PSPC1 and KDM5C expression indicates poor prognosis in prostate cancer. Human Pathology. 138. 1–11. 3 indexed citations
7.
Struck, Julian P., Maike Schnoor, Anne Offermann, et al.. (2023). The Role of Urine and Washing Cytology in Primary Transurethral Resection of Bladder Tumours. Urologia Internationalis. 107(8). 792–800. 1 indexed citations
8.
Keller, Laura, Gunhild von Amsberg, Natalia Bednarz‐Knoll, et al.. (2022). Expression Patterns and Corepressor Function of Retinoic Acid-induced 2 in Prostate Cancer. Clinical Chemistry. 68(7). 973–983. 3 indexed citations
9.
Sailer, Verena, Gunhild von Amsberg, Stefan Duensing, et al.. (2022). Experimental in vitro, ex vivo and in vivo models in prostate cancer research. Nature Reviews Urology. 20(3). 158–178. 31 indexed citations
10.
Offermann, Anne, Lars Tharun, Jochen Behrends, et al.. (2022). Inhibition of Cyclin-Dependent Kinase 8/Cyclin-Dependent Kinase 19 Suppresses Its Pro-Oncogenic Effects in Prostate Cancer. American Journal Of Pathology. 192(5). 813–823. 7 indexed citations
11.
Hellenbroich, Yorck, et al.. (2021). Lymphangioma of the fetal neck within the PIK3CA‐related‐overgrowth spectrum (PROS): A case report. SHILAP Revista de lepidopterología. 9(7). e04527–e04527. 4 indexed citations
12.
Offermann, Anne, Marie C. Hupe, Johannes Brägelmann, et al.. (2021). CDK19 as a diagnostic marker for high-grade prostatic intraepithelial neoplasia. Human Pathology. 117. 60–67. 3 indexed citations
13.
Idel, Christian, Julika Ribbat‐Idel, Dirk Rades, et al.. (2020). CDK19 as a Potential HPV-Independent Biomarker for Recurrent Disease in HNSCC. International Journal of Molecular Sciences. 21(15). 5508–5508. 7 indexed citations
14.
Ribbat‐Idel, Julika, Karl‐Ludwig Bruchhage, Dirk Rades, et al.. (2020). NR2F6 as a Prognostic Biomarker in HNSCC. International Journal of Molecular Sciences. 21(15). 5527–5527. 15 indexed citations
15.
Idel, Christian, Julika Ribbat‐Idel, Rosemarie Krupar, et al.. (2020). EVI1 as a Marker for Lymph Node Metastasis in HNSCC. International Journal of Molecular Sciences. 21(3). 854–854. 19 indexed citations
16.
Hupe, Marie C., Anne Offermann, Lars Tharun, et al.. (2020). Histomorphological analysis of false positive PI-RADS 4 and 5 lesions. Urologic Oncology Seminars and Original Investigations. 38(7). 636.e7–636.e12. 7 indexed citations
17.
Offermann, Anne, Marie C. Hupe, Verena Sailer, Axel S. Merseburger, & Sven Perner. (2019). The new ISUP 2014/WHO 2016 prostate cancer grade group system: first résumé 5 years after introduction and systemic review of the literature. World Journal of Urology. 38(3). 657–662. 13 indexed citations
18.
Klepsch, Victoria, Natascha Hermann‐Kleiter, Bojana Jakic, et al.. (2018). Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade. Nature Communications. 9(1). 1538–1538. 52 indexed citations
19.
Hupe, Marie C., Anne Offermann, Frank Perabo, et al.. (2017). Inhibitoren des Androgenrezeptor-N-Terminus’. Der Urologe. 57(2). 148–154. 6 indexed citations
20.
Adler, David, Anne Offermann, Rebecca Halbach, et al.. (2015). Clinical and Molecular Implications of MED15 in Head and Neck Squamous Cell Carcinoma. American Journal Of Pathology. 185(4). 1114–1122. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhiyong Ma Breakdown of academic impact, for papers by Qianya Qi Breakdown of academic impact, for papers by Loay Kassem Breakdown of academic impact, for papers by Sarah Beck Breakdown of academic impact, for papers by Frank Breitenbuecher Breakdown of academic impact, for papers by Shi Chang Breakdown of academic impact, for papers by Irene Rodríguez‐Hernández Breakdown of academic impact, for papers by Nikolaos Xenidis Breakdown of academic impact, for papers by John T. Isaacs
Rankless by CCL
2026